“Durable complete response in a patient with BRAF-mutated advanced melanoma with ocular and skin toxicities from BRAF/MEK targeted therapy after immune checkpoint inhibitor treatment: a case report” (2025) Dermatology Reports [Preprint]. doi:10.4081/dr.2025.10324.